Tolvaptan reduces the risk of worsening renal function in patients admitted for acute decompensated heart failure with preserved left ventricular ejection fraction: a prospective randomized controlled
27 August 2016 (00:00 - 00:00)
Organised by:
About the speaker
Fujita Health University, Toyoake (Japan)
49 More presentations in this session
Professor H. Duengen (Berlin, DE)
Doctor T. Mondritzki (Wuppertal, DE)
Doctor A. Ruwald (Copenhagen, DK)
Associate Professor N. Ermis (Malatya, TR)
Professor S. Nie (Beijing, CN)
Access the full session
The Event
ESC Congress 2016
27 August - 31 August 2016
